Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Conditions
- Allogeneic Hematopoietic Cell Transplant
- Graft Versus Host Disease
Interventions
- DRUG: reduced-dose PTCy
- DRUG: Standard dose PTCY
Sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators